Richard Fitzgerald

Dr. Richard FitzGerald is the Director of the NIHR Clinical Research Facility and a Consultant Physician in Clinical Pharmacology and Therapeutics / General Medicine at the Liverpool University Hospitals NHS Foundation Trust. He specialized in Clinical Pharmacology.

Richard has been involved in early-phase clinical trials for over 10 years, including periods working in the industry. He has been a director of the CRF since 2011 and has been the principal investigator on many early-phase and first-in-human studies (including patient cohorts and healthy volunteers) over the last five years. Richard has particular interests in the design and analysis of early-phase trials in patient groups and the development of novel pharmacodynamic techniques to generate proof of principle in both healthy volunteers and patients.

Richard is also an honorary senior lecturer in the Wolfson Centre for Personalised Medicine, where his major research interests include stratified therapies in cardiovascular disease, optimization of anti-platelet therapy, adverse drug reactions, and systematic reviews and meta-analyses.